These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Selection-by-function: efficient enrichment of cathepsin E inhibitors from a DNA library. Naimuddin M; Kitamura K; Kinoshita Y; Honda-Takahashi Y; Murakami M; Ito M; Yamamoto K; Hanada K; Husimi Y; Nishigaki K J Mol Recognit; 2007; 20(1):58-68. PubMed ID: 17173335 [TBL] [Abstract][Full Text] [Related]
28. Selection of a DNA aptamer that binds 8-OHdG using GMP-agarose. Miyachi Y; Shimizu N; Ogino C; Fukuda H; Kondo A Bioorg Med Chem Lett; 2009 Jul; 19(13):3619-22. PubMed ID: 19450981 [TBL] [Abstract][Full Text] [Related]
30. Advances in the Study of Aptamer-Protein Target Identification Using the Chromatographic Approach. Drabik A; Ner-Kluza J; Mielczarek P; Civit L; Mayer G; Silberring J J Proteome Res; 2018 Jun; 17(6):2174-2181. PubMed ID: 29703078 [TBL] [Abstract][Full Text] [Related]
31. Random mutagenesis of peptide aptamers as an optimization strategy for inhibitor screening. Bouquier N; Fromont S; Debant A; Schmidt S Methods Mol Biol; 2012; 928():97-118. PubMed ID: 22956136 [TBL] [Abstract][Full Text] [Related]
32. Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method. Hasegawa H; Sode K; Ikebukuro K Biotechnol Lett; 2008 May; 30(5):829-34. PubMed ID: 18175068 [TBL] [Abstract][Full Text] [Related]
33. In vitro selection of protein and peptide libraries using mRNA display. Takahashi TT; Roberts RW Methods Mol Biol; 2009; 535():293-314. PubMed ID: 19377989 [TBL] [Abstract][Full Text] [Related]
34. Selection and characterization of DNA aptamers with binding selectivity to Campylobacter jejuni using whole-cell SELEX. Dwivedi HP; Smiley RD; Jaykus LA Appl Microbiol Biotechnol; 2010 Aug; 87(6):2323-34. PubMed ID: 20582587 [TBL] [Abstract][Full Text] [Related]
35. A novel unstructured scaffold based on 4EBP1 enables the functional display of a wide range of bioactive peptides. See HY; Lane DP J Mol Biol; 2010 Dec; 404(5):819-31. PubMed ID: 20932973 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of vaccinia virus replication by peptide aptamers. Saccucci L; Crance JM; Colas P; Bickle M; Garin D; Iseni F Antiviral Res; 2009 Jun; 82(3):134-40. PubMed ID: 19428604 [TBL] [Abstract][Full Text] [Related]
37. Selection of aptamers for a non-DNA binding protein in the context of cell lysate. Kanoatov M; Javaherian S; Krylov SN Anal Chim Acta; 2010 Nov; 681(1-2):92-7. PubMed ID: 21035608 [TBL] [Abstract][Full Text] [Related]
38. Monomeric recombinant peptide aptamers are required for efficient intracellular uptake and target inhibition. Borghouts C; Kunz C; Delis N; Groner B Mol Cancer Res; 2008 Feb; 6(2):267-81. PubMed ID: 18314488 [TBL] [Abstract][Full Text] [Related]
39. Structural optimization of an aptamer generated from Ligand-Guided Selection (LIGS) resulted in high affinity variant toward mIgM expressed on Burkitt's lymphoma cell lines. Zümrüt HE; Batool S; Van N; George S; Bhandari S; Mallikaratchy P Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1825-1832. PubMed ID: 28363693 [TBL] [Abstract][Full Text] [Related]
40. [Selecting and affinity analysis of DNA aptamers to MPT64 protein from Mycobacterium tuberculosis]. Qin LH; Ma ZZ; Zheng RJ; Liu ZH; Lu JM; Hu ZY Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):453-8. PubMed ID: 19031807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]